Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2024.04.27.591424

Translational modelling of low and medium intensity transcranial magnetic stimulation from rodents to humans

Bolland, S. J.·Goryachev, M.·Opitz, A. J.·Tang, A.·Rodger, J.
View original source ↗Export metadata ↓

Abstract

BackgroundRodent models using subthreshold intensities of transcranial magnetic stimulation (TMS) have provided insight into the biological mechanisms of TMS but often differ from human studies in the intensity of the electric field (E-field) induced in the brain. ObjectiveTo develop a finite element method model as a guide for translation between low and medium intensity TMS rodent studies and high intensity TMS studies in humans. MethodsFEM models using three head models (mouse, rat, and human), and eight TMS coils were developed to simulate the magnetic flux density (B-field) and E-field values induced by three intensities. ResultsIn the mouse brain, maximum B-fields ranged from 0.00675 T to 0.936 T and maximum E-field of 0.231 V/m to 60.40 V/m E-field. In the rat brains maximum B-fields ranged from of 0.00696 T to 0.567 T and maximum E-fields of 0.144 V/m to 97.2 V/m. In the human brain, the S90 Standard coil could be used to induce a maximum B-field of 0.643 T and E-field of 241 V/m, while the MC-B70 coil induced 0.564 T B-field and 220 V/m E-field. ConclusionsWe have developed a novel FEM modelling tool that can help guide the replication of rodent studies using low intensity E-fields to human studies using commercial TMS coils. Modelling limitations include lack of data on dielectric values and CSF volumes for rodents and simplification of tissue geometry impacting E-field distribution, methods for mitigating these issues are discussed. A range of additional cross-species factors affecting the translation of E-fields were identified that will aid TMS E-field modelling in both humans and rodents. We present data that describes to what extent translation of brain region-specific E-field values from rodents to humans is possible and detail requirements for future improvement. A graphical abstract of the translational modelling pipeline from this study is provided below (Figure A.1). O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=113 SRC="FIGDIR/small/591424v1_figA1.gif" ALT="Figure 1"> View larger version (53K): org.highwire.dtl.DTLVardef@5aa978org.highwire.dtl.DTLVardef@2c2128org.highwire.dtl.DTLVardef@13507c1org.highwire.dtl.DTLVardef@9044d6_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOFigure A.1:C_FLOATNO A translational modelling pipeline describing the use of structural imaging data for FEM modelling purposes and the comparison of brain region-specific rodent and human LI-rTMS E-field values. C_FIG HighlightsO_LIClinical translation of rodent TMS studies is challenging due to the differences in coil and brain size and shape between rodents and humans. C_LIO_LIWe have built a FEM model for the accurate replication of TMS-derived E-fields validated in rodent models in multiple brain regions in humans. C_LIO_LIThis model is useful in designing stimulation parameters for humans based on rodent studies. C_LIO_LIThis model is a critical part of a translational pipeline for evidence based TMS. C_LI

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bolland, S. J., Goryachev, M., Opitz, A. J., Tang, A., Rodger, J.. 2024-04-29. Translational modelling of low and medium intensity transcranial magnetic stimulation from rodents to humans. https://doi.org/10.1101/2024.04.27.591424

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗